Formic Acid → N-(4-(methoxymethyl)-5-(thiazolo[5,4-c]pyridin-2-yl)thiazol-2-yl)acetamide
反応式
C(N(CC)C([S:6][C:7]1[CH:8]=[N:9][CH:10]=[CH:11][C:12]=1[NH:13][C:14]([C:16]1[S:20][C:19]([NH:21][C:22](=[O:24])[CH3:23])=[N:18][C:17]=1[CH2:25][O:26][CH3:27])=O)=S)C.C(O)=O.Cl.CO>C(Cl)Cl>[CH3:27][O:26][CH2:25][C:17]1[N:18]=[C:19]([NH:21][C:22](=[O:24])[CH3:23])[S:20][C:16]=1[C:14]1[S:6][C:7]2[CH:8]=[N:9][CH:10]=[CH:11][C:12]=2[N:13]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
Crude 4-(2-acetamido-4-(methoxymethyl)thiazole-5-carboxamido)pyridin-3-yl diethylcarbamodithioate (4.485 g, 9.89 mmol) and formic acid (0.379 mL, 9.89 mmol) were added to a 150 mL round-bottomed flask, and the solution was stirred at reflux for approximately 24 hours until LCMS indicated that the reaction was complete. The formic acid was removed, and the reaction was quenched by addition of 1 N NaOH. No precipitate formed, and the solution was made neutral with HCl and extracted with EtOAc (5×75 mL) to provide crude product. The organic solution was adsorbed onto a plug of silica gel and chromatographed through a Redi-Sep® pre-packed silica gel column (40 g), eluting with a gradient of 2% to 10% 2 M NH3.MeOH in DCM, to provide N-(4-(methoxymethyl)-5-(thiazolo[5,4-c]pyridin-2-yl)thiazol-2-yl)acetamide (0.446 g, 1.39 mmol, 14.1% yield). LCMS (M+H) 321.1 calc. for C13H13N4O2S2 321.39, 1H NMR (400 MHz, CD3OD): δ ppm 9.42 (s, 1H), 8.61 (d, J=6.5 Hz, 1H), 8.18 (d, J=6.5 Hz, 1H), 4.82 (s, 2H), 3.51 (s, 3H), 2.27 (s, 3H).
後処理
- temperatureat reflux for approximately 24 hours until LCMS
- customThe formic acid was removed
- customthe reaction was quenched by addition of 1 N NaOH
- customNo precipitate formed
- extractionextracted with EtOAc (5×75 mL)
- customto provide crude product
- customchromatographed through a Redi-Sep® pre-packed silica gel column (40 g)
- washeluting with a gradient of 2% to 10% 2 M NH3
出典と根拠
- ORDレコード
- ord-9dc397ec797045a68fd174901612af9c
- 出典データセット
- uspto-grants-2009_04
- 特許番号
- US07514566B2
反応ノート
読み込み中…